(Q37326414)

English

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer

scientific article published on September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Anika Agarwal

1

1 reference

Europe PubMed Central

19 August 2017

Lidija Covic

2

1 reference

Europe PubMed Central

19 August 2017

Leila M Sevigny

3

1 reference

Europe PubMed Central

19 August 2017

Nicole C Kaneider

4

1 reference

Europe PubMed Central

19 August 2017

Katherine Lazarides

5

1 reference

Europe PubMed Central

19 August 2017

Gissou Azabdaftari

6

1 reference

Europe PubMed Central

19 August 2017

Sheida Sharifi

7

1 reference

Europe PubMed Central

19 August 2017

Athan Kuliopulos

8

1 reference

Europe PubMed Central

19 August 2017

publication date

1 September 2008

1 reference

Europe PubMed Central

19 August 2017

Molecular Cancer Therapeutics

1 reference

Europe PubMed Central

19 August 2017

7

1 reference

Europe PubMed Central

19 August 2017

9

1 reference

Europe PubMed Central

19 August 2017

2746-2757

1 reference

Europe PubMed Central

19 August 2017

'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

A cancer cell metalloprotease triad regulates the basement membrane transmigration program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

High-resolution serum proteomic features for ovarian cancer detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

How matrix metalloproteinases regulate cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Evaluation of some newer matrix metalloproteinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Thrombin receptor overexpression in malignant and physiological invasion processes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

6 September 2017

Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

14 September 2017

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

28 September 2017

Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

28 September 2017

Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

26 June 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Differential actions of PAR2 and PAR1 in stimulating human endothelial cell exocytosis and permeability: the role of Rho-GTPases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

2 September 2018

Plasmin Desensitization of the PAR1 Thrombin Receptor: Kinetics, Sites of Truncation, and Implications for Thrombolytic Therapy†

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2735132

3 December 2018

Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focus on epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and activity of MMPS and their regulators in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases target protease-activated receptors on the tumor cell surface

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversing systemic inflammatory response syndrome with chemokine receptor pepducins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18790755

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1535-7163.MCT-08-0177

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37326414&oldid=1700637844"